MEGAN HOFFMAN: Open Payments
NPI 1386931590 · HARRISBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 21 payments from 12 companies in 2025. Trend: 2023 $51 · 2024 $544 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $60 |
| Lilly USA, LLC | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 3 | $31 |
| Braeburn Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Verona Pharma, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: MOUNJARO, BREZTRI, REXULTI, TRELEGY ELLIPTA, VOQUEZNA, BRIXADI, GEMTESA, Ohtuvayre.
Industry payments across IL — which companies pay providers there.
